BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Wang P, Yang W, Shan Y, Zhang Q, Wu H. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis. Cancer Biol Ther 2019;20:729-39. [PMID: 30915884 DOI: 10.1080/15384047.2018.1529121] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang N, Hu X, He S, Ding W, Wang F, Zhao Y, Huang Z. LncRNA MSC-AS1 promotes osteogenic differentiation and alleviates osteoporosis through sponging microRNA-140–5p to upregulate BMP2. Biochemical and Biophysical Research Communications 2019;519:790-6. [DOI: 10.1016/j.bbrc.2019.09.058] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
2 Wang C, Wang Y, Fu Z, Huang W, Yu Z, Wang J, Zheng K, Zhang S, Li S, Chen J. MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1. Front Oncol 2022;12:837581. [DOI: 10.3389/fonc.2022.837581] [Reference Citation Analysis]
3 Kou X, Zhu J, Xie X, Hao M, Zhao Y. Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration. Turk J Gastroenterol 2020;31:860-7. [PMID: 33625998 DOI: 10.5152/tjg.2020.19485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang J, Liu S, Shi J, Liu H, Li J, Zhao S, Yi Z. The Role of lncRNAs in Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. Curr Stem Cell Res Ther 2020;15:243-9. [PMID: 31880266 DOI: 10.2174/1574888X15666191227113742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Seyed Hosseini E, Nikkhah A, Sotudeh A, Alizadeh Zarei M, Izadpanah F, Nikzad H, Haddad Kashani H. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant). Cancer Cell Int 2021;21:447. [PMID: 34425840 DOI: 10.1186/s12935-021-02125-1] [Reference Citation Analysis]
6 Cao C, Zhong Q, Lu L, Huang B, Li J, Meng L, Wei H. Long noncoding RNA MSC-AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1. Cancer Med 2020;9:5174-84. [PMID: 32489020 DOI: 10.1002/cam4.3080] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Xia X, Zhang H, Xia P, Zhu Y, Liu J, Xu K, Yuan Y. Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma. Front Oncol 2021;11:733595. [PMID: 34527595 DOI: 10.3389/fonc.2021.733595] [Reference Citation Analysis]
8 Gu C, Meng Y, Meng Q, Fan W, Ye M, Zhang Q, Zhang N, Li L. Exploring the Potential Key IncRNAs with Endometriosis by Construction of a ceRNA Network. Int J Gen Med 2021;14:4161-70. [PMID: 34385836 DOI: 10.2147/IJGM.S321648] [Reference Citation Analysis]
9 Sempere LF, Powell K, Rana J, Brock AA, Schmittgen TD. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. Cancer Metastasis Rev 2021;40:761-76. [PMID: 34591242 DOI: 10.1007/s10555-021-09995-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nie Y, Li J, Wu W, Guo D, Lei X, Zhang T, Wang Y, Mao Z, Zhang X, Song W. A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma. Front Oncol 2021;11:706915. [PMID: 34604045 DOI: 10.3389/fonc.2021.706915] [Reference Citation Analysis]
11 Hu Z, Li L, Cheng P, Liu Q, Zheng X, Peng F, Zhang Q. lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A. J Cell Biochem 2020;121:4085-93. [PMID: 31916281 DOI: 10.1002/jcb.29594] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
12 Zhao F, Wei C, Cui MY, Xia QQ, Wang SB, Zhang Y. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis. Aging (Albany NY) 2020;12:9380-404. [PMID: 32420903 DOI: 10.18632/aging.103214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zhao Y, Yuan D, Zhu D, Xu T, Huang A, Jiang L, Liu C, Qian H, Bu X. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p. J Ovarian Res 2021;14:109. [PMID: 34454554 DOI: 10.1186/s13048-021-00857-2] [Reference Citation Analysis]
14 Ashrafizadeh M, Rabiee N, Prem Kumar A, Sethi G, Zarrabi A, Wang Y. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. Drug Discov Today 2022:S1359-6446(22)00202-1. [PMID: 35589014 DOI: 10.1016/j.drudis.2022.05.012] [Reference Citation Analysis]
15 Li K, Liu FF. Analysis of competing endogenous RNA (ceRNA) crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 2022. [PMID: 35385217 DOI: 10.1002/alr.23008] [Reference Citation Analysis]
16 Zhang G, Zhu Y, Jin C, Shi Q, An X, Song L, Gao F, Li S. CircRNA_0078767 promotes osteosarcoma progression by increasing CDK14 expression through sponging microRNA-330-3p. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109903] [Reference Citation Analysis]
17 Li C, Feng S, Chen L. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Mol Cell Biochem 2021;476:699-713. [PMID: 33106913 DOI: 10.1007/s11010-020-03937-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gui D, Cao H. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458. In Vitro Cell Dev Biol Anim 2020;56:24-33. [PMID: 31950433 DOI: 10.1007/s11626-019-00415-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Tsai WL, Wang CY, Lee YC, Tang WC, Anuraga G, Ta HDK, Wu YF, Lee KH. A New Light on Potential Therapeutic Targets for Colorectal Cancer Treatment. Biomedicines 2021;9:1438. [PMID: 34680556 DOI: 10.3390/biomedicines9101438] [Reference Citation Analysis]
20 Zhuang M, Chaolumen Q, Li L, Chen B, Su Q, Yang Y, Zhang X. MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis. Biochem Biophys Res Commun 2020;527:511-7. [PMID: 32423796 DOI: 10.1016/j.bbrc.2020.03.170] [Reference Citation Analysis]
21 Zhang L, Zhao G, Ji S, Yuan Q, Zhou H. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Med Sci Monit 2020;26:e921594. [PMID: 32155139 DOI: 10.12659/MSM.921594] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
22 Zhou Y, Li K, Dai T, Wang H, Hua Z, Bian W, Wang H, Chen F, Ai X. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A. Aging (Albany NY) 2021;13:16267-86. [PMID: 34148029 DOI: 10.18632/aging.203155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Jin X, Qiao L, Fan H, Liao C, Zheng J, Wang W, Ma X, Yang M, Sun X, Zhao W. Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression. Int J Med Sci 2021;18:546-54. [PMID: 33390824 DOI: 10.7150/ijms.51947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu Y, Li L, Wu X, Qi H, Gao Y, Li Y, Chen D. MSC-AS1 induced cell growth and inflammatory mediators secretion through sponging miR-142-5p/DDX5 in gastric carcinoma. Aging (Albany NY) 2021;13:10387-95. [PMID: 33819916 DOI: 10.18632/aging.202800] [Reference Citation Analysis]
25 Liu Y, Meng W, Cao H, Wang B. Identification of MSC-AS1, a novel lncRNA for the diagnosis of laryngeal cancer. Eur Arch Otorhinolaryngol 2021;278:1107-18. [PMID: 33079247 DOI: 10.1007/s00405-020-06427-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Ramya Devi KT, Karthik D, Mahendran T, Jaganathan MK, Hemdev SP. Long noncoding RNAs: role and contribution in pancreatic cancer. Transcription 2021;12:12-27. [PMID: 34036896 DOI: 10.1080/21541264.2021.1922071] [Reference Citation Analysis]
27 Pant T, Juric M, Bosnjak ZJ, Dhanasekaran A. Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering. Front Cardiovasc Med 2021;8:737512. [PMID: 34660740 DOI: 10.3389/fcvm.2021.737512] [Reference Citation Analysis]
28 Wang J, Zhu M, Ye L, Chen C, She J, Song Y. MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway. Aging (Albany NY) 2020;12:1141-58. [PMID: 31955152 DOI: 10.18632/aging.102672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Yang X, Xin N, Qu HJ, Wei L, Han Z. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis. Anat Rec (Hoboken) 2020;303:3024-34. [PMID: 31930662 DOI: 10.1002/ar.24367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Ferretti VA, León IE. Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma. Curr Treat Options Oncol 2021;22:41. [PMID: 33745006 DOI: 10.1007/s11864-021-00839-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yao H, Yang L, Tian L, Guo Y, Li Y. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2). Cancer Cell Int 2020;20:138. [PMID: 32368184 DOI: 10.1186/s12935-020-01202-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
32 Li S, Yang S, Qiu C, Sun D. LncRNA MSC-AS1 facilitates lung adenocarcinoma through sponging miR-33b-5p to up-regulate GPAM. Biochem Cell Biol 2021;99:241-8. [PMID: 33821667 DOI: 10.1139/bcb-2020-0239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Luo J, Xu J, Ou L, Zhou Y, Yun H, Yang Y, Wu X, Wang Y. Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients. J Int Med Res 2021;49:3000605211049946. [PMID: 34617815 DOI: 10.1177/03000605211049946] [Reference Citation Analysis]
34 Yang W, Ge F, Lu S, Shan Z, Peng L, Chai J, Liu H, Li B, Zhang Z, Huang J, Hua Y, Zhang Y. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis. Front Med (Lausanne) 2021;8:795427. [PMID: 34926534 DOI: 10.3389/fmed.2021.795427] [Reference Citation Analysis]
35 Ma Y, Jin Y, Li C, Liu Y, Wang D. LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression. Exp Dermatol 2021. [PMID: 34218464 DOI: 10.1111/exd.14427] [Reference Citation Analysis]
36 Shen P, Yang Y, Liu G, Chen W, Chen J, Wang Q, Gao H, Fan S, Shen S, Zhao X. CircCDK14 protects against Osteoarthritis by sponging miR-125a-5p and promoting the expression of Smad2. Theranostics 2020;10:9113-31. [PMID: 32802182 DOI: 10.7150/thno.45993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]